Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT01239537

Completed

Swine Flu (Influenza A H1N1) Follow on Vaccine Study

Influenza
NCT01641042

Completed

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Infections, Meningococcal
NCT02692859

Completed

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus Influenza
NCT02145234

Completed

Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects

Healthy Adults
NCT03212911

Unknown

HBV Vaccination in HIV-infected Adults

Hepatitis B Vaccination, HIV
NCT01077531

Terminated

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Arthritis, Rheumatoid
NCT02917304

Completed

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

Influenza, Human
NCT00264576

Completed

Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults

Influenza Disease; Flu
NCT02118766

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic
NCT00376779

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b
NCT00197158

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B
NCT00136331

Completed

Study of a Pandemic Influenza Vaccine

Influenza
NCT01152814

Completed

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

Seasonal Influenza
NCT01602367

Terminated

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

Hypertension
NCT01361555

Terminated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Depression
NCT01650324

Completed

A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects

Diabetes Mellitus, Type 2
NCT01906190

Completed

Persistence of Immune Response After Vaccination With Influenza Vaccine

Influenza, Human | Immunisation Reaction
NCT01304810

Completed

A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

Smoking Cessation | Nicotine Dependence
NCT01178346

Completed

Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

Smoking Cessation
NCT01254955

Completed

Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients

Organ Transplantation
NCT01357265

Completed

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

Influenza
NCT00828022

Unknown

Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer (SMC4692)

Measles | Non-Small Cell Lung Cancer
NCT00144313

Completed

VaxTeen Hepatitis B Vaccine Booster Study

Hepatitis
NCT00430534

Completed

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Epstein Barr Virus (EBV) Infection
NCT00423566

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Tuberculosis
NCT00052130

Unknown

Vaccine Therapy for Patients With Stage III Melanoma

Malignant Melanoma
NCT00052156

Unknown

Vaccine Therapy for Patients With Stage IV Melanoma

Malignant Melanoma
NCT07608328

Not yet recruiting

Azithromycin to Modify Bronchiectasis Exacerbation Risk (AMBER)

Bronchiectasis | Bronchiectasis Adult | Non-cystic Fibrosis Bronchiectasis | Bronchiectasis With Acute Exacerbation
NCT06205589

Not yet recruiting

Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB

Tuberculosis, Pulmonary
NCT06436703

Completed

A Study About Modified RNA Vaccines Against Influenza in Healthy Adults

Influenza, Human
NCT06831786

Completed

Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

COVID - 19
NCT05507671

Active, not recruiting

The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines (SARS-CoV-2)

COVID-19
NCT03457194

Active, not recruiting

Optimising Protection for Pregnant Women and Infants With Maternal Vaccination (OPTIWIN)

Obesity
NCT03739112

Completed

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases
NCT04865497

Completed

Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old

Dysentery, Bacillary | Dysentery
NCT03439657

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster
NCT00574600

Completed

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

HIV Infections
NCT04364399

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Mumps
NCT03600428

Completed

Safety of LAIV4 in Children With Asthma

Vaccine Adverse Reaction | Vaccine Reaction | Asthma | Influenza | Asthma in Children | Wheezing
NCT02114333

Completed

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Herpes Zoster | Shingles
NCT04108845

Unknown

Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months

Pneumonia, Pneumococcal
NCT01578317

Completed

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

Influenza
NCT03180359

Unknown

Vaccines Immunogenicity in Renal, Hepatic, Cardiac or Pulmonary Transplanted Children (COVAGREF)

Transplantation
NCT01659086

Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

Influenza
NCT00792909

Completed

Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A

Infections, Streptococcal
NCT00959049

Completed

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

Influenza
NCT01934127

Completed

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age

Influenza
NCT00496054

Completed

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

Gastroenteritis | Rotavirus
NCT00560950

Completed

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Pneumococcal Infection
NCT01852591

Completed

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant (PCV13)

Multiple Myeloma

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations